A Role for Macrophages in the Pathogenesis of Type 1 Diabetes

References

• Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes. Lancet 1981; 2: 1363–5
   PubMed Web of Science ®Google Scholar
• Rossini AA, Mordes JP, Like AA. Immunology of insulin-dependent diabetes mellitus. Ann Rev Immunol 1985; 3: 289–320
   PubMed Web of Science ®Google Scholar
• Gepts W. Islet morphology in type I diabetes. Behring Inst Mitt 1984; 75: 33–8
   Google Scholar
• Mordes JP, Desemone J, Rossini AA. The BB rat. Diabetes/Metabolism Rev 1987; 3: 725–50
   PubMed Web of Science ®Google Scholar
• Kolb H. Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes/Metabolism Rev 1987; 3: 751–78
   PubMed Web of Science ®Google Scholar
• Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976; 193: 415–7
   PubMed Web of Science ®Google Scholar
• Like AA, Appel MC, Williams RM, Rossini AA. Streptozotocin-induced pancreatic insulitis in mice. Lab Invest 1978; 38: 470–86
   PubMedGoogle Scholar
• Kantwerk G, Cobbold S, Waldmann H, Kolb H. L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice. Clin exp Immunol 1987; 70: 585–92
   PubMedGoogle Scholar
• Kolb-Bachofen V, Epstein S, Kiesel U, Kolb H. Low-dose streptozocin-induced diabetes in mice. Diabetes 1988; 37: 21–7
   PubMed Web of Science ®Google Scholar
• Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol 1967; 126: 201–5
   PubMed Web of Science ®Google Scholar
• Oschilewski M, Schwab E, Kiesel U, Opitz U, Stunkel K, Kolb-Bachofen V, Kolb H. Administration of silica or monoclonal antibody to Thy-1 prevents low-dose streptozotocin induced diabetes in mice. Immunol Lett 1986; 12: 289–95
   PubMedGoogle Scholar
• Koevary S, Rossini AA, Stoller W, Chick W, Williams RM. Passive transfer of diabetes in the BB W rat. Science 1983; 220: 727–8
   PubMed Web of Science ®Google Scholar
• Like AA, Biron CA, Weringer EJ, Byman K, Sroczynski E, Guberski DL. Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med 1986; 164: 1145–59
   PubMed Web of Science ®Google Scholar
• Jacobson JD, Markmann JF, Brayman KL, Barker CF. Prevention of recurrent autoimmune diabetes in BB rats by anti-asialo-GM 1 antibody. Diabetes 1988; 37: 838–41
   PubMed Web of Science ®Google Scholar
• Handler ES, Mordes JP, Seals J, Koevary S, Like AA, Nakano K, Rossini AA. Diabetes in the Bio-Breeding Worcester (BB/W) rat: induction and acceleration by spleen cell conditioned media. J Clin Invest 1985; 76: 1692–4
   Google Scholar
• Kolb-Bachofen V, Kolb H. New concept of insulitis and B-islet cell destruction. Diabetes 1983; 32: 22A
   Google Scholar
• Logothetopoulos J, Valiquette N, Madura E, Cvet D. The onset and progression of pancreatic insulitis in the overt, spontaneously diabetic, young adult BB rat studied by pancreatic biopsy. Diabetes 1984; 33: 33–6
   PubMed Web of Science ®Google Scholar
• Oschilewski U, Kiesel U, Kolb H. Administration of silica prevents diabetes in BB-rats. Diabetes 1985; 34: 197–9
   PubMed Web of Science ®Google Scholar
• Kiesel U, Oschilewski M, Kantwerk G, Maruta M, Hanenberg H, Treichel U, Kolb-Bachofen V, Hartung HP, Kolb H. Essential role of macrophages in the development of type 1 diabetes in BB rats. Transplant Proc 1986; 18: 1525–7
   Web of Science ®Google Scholar
• Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of prediabetic BB rats. Diabetologia 1989, in press
   Google Scholar
• Lee K., Kim M., Amano K, Pak C., Jaworski M., Mehta J., Yoon J. Preferential infiltration of macrophages during early stages of insulitis in diabetes-prone BB rats. Diabetes 1988; 37: 1053–7
   PubMed Web of Science ®Google Scholar
• Walker R., Bone A., Cooke A., Baird J. Distinct macrophage subpopuilations in pancreas of prediabetic BB/E rats. Possible role for macrophages in pathogenesis of IDDM. Diabetes 1988; 37: 1301–4
   PubMed Web of Science ®Google Scholar
• Lee K., Pak C., Amano K., Yoon J. Prevention of lymphocytic thyroiditis and insulitis in diabetes-prone BB rats by the depletion of macrophages. Diabetologia 1988; 31: 400–2
   PubMedGoogle Scholar
• Charlton B, Bacelj A, Mandel TE. Administration of silica particles or anti-Lyt2 antibody prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes 1988; 37: 930–5
   PubMed Web of Science ®Google Scholar
• Lee K-U, Amano K, Yoon J.-W. Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 1988; 37: 989–91
   PubMed Web of Science ®Google Scholar
• Seemayer TA, Colle E, Tannenbaum GS, Oligny LL, Guttmann RD, Goldman H. Spontaneous diabetes mellitus syndrome in the rat. III. Pancreatic alterations in aglycosuric and untreated diabetic BB Wistar-derived rats. Metabolism 1983; 32: 26–32, Suppl 1
   PubMedGoogle Scholar
• Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG. Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc Natl Acad Sci USA 1982; 79: 927–31
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Bendtzen K, Nerup J, Egeberg J, Nielsen JH. Mechanisms of pancreatic islet cell destruction. Dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans. Allergy 1986; 41: 250–9
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH. Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 1986; 29: 63–7
   PubMed Web of Science ®Google Scholar
• Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-t, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 1988; 37: 133–6
   PubMed Web of Science ®Google Scholar
• Debray-Sachs M, Assan R, Bailey D, Hamburger J. Immunologic.-L'inhinition fonctionnelle de cellules pancreatiques isolées, nouvelle technique de detection de la cytotoxicité des macrophages. C R Acad Sc Paris 1978; 287: 1161–4
   Google Scholar
• Burkhard V., Appels B., Kolb H. In vivo cytotoxic activity of macrophages against isolated islet cells. Diabetologia 1988; 37(A)21
   Google Scholar
• Rossini AA, Mordes JP, Handler ES. Perspectives in diabetes. Speculations on etiology of diabetes mellitus. Tumbler hypothesis. Diabetes 1988; 37: 257–61
   PubMed Web of Science ®Google Scholar
• Majno G, Joris I, Handler ES, Desemone J., Mordes JP, Rossini AA. A pancreatic venular defect in the BB/Wor rat. Amer. J. Pathol 1987; 128: 210–15
   PubMed Web of Science ®Google Scholar
• Leiter EH. Murine macrophages and pancreatic flcells. Chemotactic properties of insulin and β-cytostatic action of interleukin 1. J. Exp Med 1987; 166: 1174–9
   PubMed Web of Science ®Google Scholar
• Vetterlein F, Petho A, Schmidt G. Morphometric investigation of the microvascular system of pancreatic exocrine and endocrine tissue in the rat. Microvasc Res 1987; 34: 231–8
   Google Scholar
• Bottazzo GF, Pujol-Borrell R, Hanafusa T. Role of aberrant HLA-Dr expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; 2: 115–8
   Google Scholar
• Sarvetinick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988; 52: 773–82
   Google Scholar
• Lo D, Burkly LC, Widera G, Cowing C, Flavell RA, Palmiter RD, Brinster RL. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 1988; 53: 159–68
   PubMed Web of Science ®Google Scholar
• Allison J, Campbell IL, Morahan G, Mandel TE, Harrison LC, Miller JFAP. Diabetes in transgenic mice resulting from over-expression of Class I. histocompatibility molecules in pancreatic β cells. Nature 1988; 333: 529–33
   PubMed Web of Science ®Google Scholar